Literature DB >> 19530970

Vitamin K epoxide reductase complex 1 (VKORC1) haplotypes in healthy Hungarian and Roma population samples.

Csilla Sipeky1, Veronika Csongei, Luca Jaromi, Eniko Safrany, Noemi Polgar, Lilla Lakner, Melinda Szabo, Istvan Takacs, Bela Melegh.   

Abstract

The aim of this work was to determine the VKORC1 haplotype profile in healthy Hungarian and Roma population samples, and to compare our data with other selected populations. Using haplotype tagging SNPs (G-1639A, G9041A and C6009T), we characterized Hungarian (n = 510) and Roma (n = 451) population samples with regard to VKORC1*1, *2, *3 and *4 haplotypes. In the Hungarian samples, the VKORC1*1, *2, *3 and *4 haplotypes accounted for 3, 39, 37 and 21%, respectively and by contrast, in the Roma population samples the VKORC1 variants were 5, 30, 46 and 19%, respectively. Comparing the genotypes of Roma and Hungarian populations, difference was found in the *2/*2 (6.87 vs 13.5%), *2/*4 (13.9 vs 19.2%) and *3*3 (21.9 vs 13.7%) VKORC1 haplotype combinations. Comparing each group with the others, and our data with findings published previously by other groups, the VKORC1 genetic profile in Hungarians was more similar to European Caucasians and Americans with European descent than to Roma samples. Clear differences could be detected between Roma versus Hungarians and European or American Caucasians; the Roma population had only minor similarities with data from India.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19530970     DOI: 10.2217/pgs.09.46

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  9 in total

1.  Multivariate analysis of the relation between diet and warfarin dose.

Authors:  Morten Arendt Rasmussen; Jane Skov; Else-Marie Bladbjerg; Johannes J Sidelmann; Marianne Vamosi; Jørgen Jespersen
Journal:  Eur J Clin Pharmacol       Date:  2011-09-21       Impact factor: 2.953

2.  Marked Differences of Haplotype Tagging SNP Distribution, Linkage, and Haplotype Profile of APOA5 Gene in Roma Population Samples.

Authors:  Katalin Sumegi; Balazs Duga; Bela I Melegh; Zsolt Banfai; Erzsebet Kovesdi; Anita Maasz; Bela Melegh
Journal:  Pathol Oncol Res       Date:  2017-01-19       Impact factor: 3.201

Review 3.  High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature.

Authors:  Csilla Sipeky; Agnes Weber; Melinda Szabo; Bela I Melegh; Ingrid Janicsek; Greta Tarlos; Istvan Szabo; Katalin Sumegi; Bela Melegh
Journal:  Mol Biol Rep       Date:  2013-05-05       Impact factor: 2.316

4.  Lower carrier rate of GJB2 W24X ancestral Indian mutation in Roma samples from Hungary: implication for public health intervention.

Authors:  Csilla Sipeky; Petra Matyas; Marton Melegh; Ingrid Janicsek; Renata Szalai; Istvan Szabo; Reka Varnai; Greta Tarlos; Alma Ganczer; Bela Melegh
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

5.  Hodgkin disease therapy induced second malignancy susceptibility 6q21 functional variants in roma and hungarian population samples.

Authors:  Dalma Varszegi; Balazs Duga; Bela I Melegh; Katalin Sumegi; Peter Kisfali; Anita Maasz; Bela Melegh
Journal:  Pathol Oncol Res       Date:  2013-12-05       Impact factor: 3.201

6.  Is there any association between osteoporotic vertebral fracture and vitamin K epoxide reductase complex subunit-1 polymorphism in Turkish society? A pilot study.

Authors:  Merih Ozgen; Didem Turgut Cosan; Fulya Doganer; Ahu Soyocak; Onur Armagan; Selen Kuzgun; Ayse Merve Aydogan; Hasan Veysi Gunes; Irfan Degirmenci; Fezan Mutlu
Journal:  Clinics (Sao Paulo)       Date:  2019-03-14       Impact factor: 2.365

7.  Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations.

Authors:  Agnes Nagy; Csilla Sipeky; Renata Szalai; Bela Imre Melegh; Petra Matyas; Alma Ganczer; Kalman Toth; Bela Melegh
Journal:  BMC Genet       Date:  2015-09-03       Impact factor: 2.797

8.  Analysis of CYP2C9*2, CYP2C9*3 and VKORC1 -1639 G>A polymorphisms in a population from South-Eastern Europe.

Authors:  Anca D Buzoianu; Adrian P Trifa; Dafin F Mureşanu; Sorin Crişan
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

9.  Characterization of ADME genes variation in Roma and 20 populations worldwide.

Authors:  Tatjana Škarić-Jurić; Željka Tomas; Matea Zajc Petranović; Nada Božina; Nina Smolej Narančić; Branka Janićijević; Marijana Peričić Salihović
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.